Journal of clinical psychopharmacology
-
J Clin Psychopharmacol · Dec 2005
Randomized Controlled TrialOxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial.
Impulsive aggression is a common clinically significant symptom, but there are few controlled studies evaluating drug treatment. This study evaluated oxcarbazepine in patients with impulsive aggression and whether diagnosis or other baseline characteristics predict response. ⋯ Oxcarbazepine appears to benefit adults with clinically significant impulsive aggression.